ARYA Sciences Acquisition Corp IV

ARYA Sciences Acquisition Corp IV (Nasdaq: ARYD) is a blank-check company targeting the life sciences and healthcare sector, sponsored by ARYA Sciences Management Corp, an affiliate of New York-based investment firm Perceptive Advisors. ARYD completed its initial public offering in 2021 and represents the fourth vehicle in the ARYA Sciences SPAC series, which has consistently concentrated on biopharmaceutical and biotechnology opportunities. The company filed its Form 10-Q with the Securities and Exchange Commission on August 12, 2021, at which point it had not yet identified a definitive business combination target and remained in its search phase. Sign up on SpacDesk for full filing history, timeline data, and analytics on ARYD and the broader SPAC market.